418 related articles for article (PubMed ID: 22321707)
21. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
[TBL] [Abstract][Full Text] [Related]
22. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
Li J; Dai A; Hu R; Zhu L; Tan S
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
[TBL] [Abstract][Full Text] [Related]
27. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM
J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384
[TBL] [Abstract][Full Text] [Related]
28. Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation.
Bo QL; Chen YH; Yu Z; Fu L; Zhou Y; Zhang GB; Wang H; Zhang ZH; Xu DX
Mol Cell Endocrinol; 2016 Mar; 423():51-9. PubMed ID: 26773728
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of Paeoniflorin on TNF-α-induced TNF-α Receptor Type I /Nuclear Factor-κB Signal Transduction in Endothelial Cells].
Ma SH; Wang HF; Liu JL; Huo XP; Zhao XR; Cao QW; Liu QS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):339-44. PubMed ID: 27236893
[TBL] [Abstract][Full Text] [Related]
30. [Effect of peroxisome proliferators activated receptor gamma and its ligand on airway mucus hypersecretion in rats].
Liu WJ; Li WC; Xu ZB; Feng YL
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):282-6. PubMed ID: 19576043
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation.
Li Q; Zhang H; Yan X; Zhao Z; Qiu J; Hu L; Jiang S; Kong Q; Sun J; Li L
Pulm Pharmacol Ther; 2023 Apr; 79():102197. PubMed ID: 36690317
[TBL] [Abstract][Full Text] [Related]
32. Rosiglitazone protects rat liver against acute liver injury associated with the NF-κB signaling pathway.
Chen W; Lin YJ; Zhou XY; Chen H; Jin Y
Can J Physiol Pharmacol; 2016 Jan; 94(1):28-34. PubMed ID: 26394869
[TBL] [Abstract][Full Text] [Related]
33. [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells].
Xu SH; Wang KF; Xu CS; Xie LD
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):512-7. PubMed ID: 21924076
[TBL] [Abstract][Full Text] [Related]
34. Role of TLR4/NF-κB Signalling Pathway in Pulmonary Arterial Hypertension in Patients with Chronic Obstructive Pulmonary Disease.
Zuo ZT; Ma Y; Sun Y; Bai CQ; Zhou HY; Chen BH
J Coll Physicians Surg Pak; 2020 Jun; 30(6):568-573. PubMed ID: 32703338
[TBL] [Abstract][Full Text] [Related]
35. [Regulatory effects of lanthanum chloride on the activation of nuclear factor kappa B inhibitor kinase beta induced by tumor necrosis factor alpha].
Guo F; He F; Xiu M; Lou YL; Xie A; Liu F; Li GH
Zhonghua Shao Shang Za Zhi; 2013 Dec; 29(6):531-6. PubMed ID: 24495640
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice.
Cheng Y; Li S; Wang M; Cheng C; Liu R
Med Sci Monit; 2018 Dec; 24():9045-9053. PubMed ID: 30544130
[TBL] [Abstract][Full Text] [Related]
37. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Ye P; Fang H; Zhou X; He YL; Liu YX
Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
[TBL] [Abstract][Full Text] [Related]
38. Effects of DHA-enriched fish oil on gene expression levels of p53 and NF-κB and PPAR-γ activity in PBMCs of patients with T2DM: A randomized, double-blind, clinical trial.
Naeini Z; Toupchian O; Vatannejad A; Sotoudeh G; Teimouri M; Ghorbani M; Nasli-Esfahani E; Koohdani F
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):441-447. PubMed ID: 31831363
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone attenuates the metalloprotease/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NFκB signaling.
Hou G; Yin Y; Han D; Wang QY; Kang J
Int J Chron Obstruct Pulmon Dis; 2015; 10():715-24. PubMed ID: 25897215
[TBL] [Abstract][Full Text] [Related]
40. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D
Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
